Article
Beneficial changes in the gut microbiome of patients with multiple sclerosis after consumption of Neu-REFIX B-glucan in a clinical trial
2023-09-08
Abstract excerpt
<h4>Background</h4> Multiple sclerosis (MS) is a debilitating demyelinating disease and recent evidences are giving cues towards correlation of disease severity to gut microbiome dysbiosis. However, there haven’t been any reported interventions that beneficially modifies the gut microbiome to yield a clinically discernible improvement. Having earlier reported the clinical effects of a biological response modifier...
Topics
Open a Topic to create a Post that cites this publication.
- Clostridium difficile and Clostridium perfringens research
- Gastrointestinal motility and disorders
- Ginseng Biological Effects and Applications
- Gut microbiota and health
- Multiple Sclerosis Research Studies
- Mycobacterium research and diagnosis
- Probiotics and Fermented Foods
- Salivary Gland Disorders and Functions
Identifiers and source
- Literature Corpus work
- ee7eaaea-c5e4-5e89-b7ca-07e39096669b
- DOI
- 10.1101/2023.09.07.23295172
